![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Announces Sale of Common Stock in Its At-the-Market Public Offering
April 11, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., April 11, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Host Analyst Event in New York City
April 03, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., April 3, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
March 14, 2013 07:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., March 14, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the ROTH 25th Annual Growth Stock Conference
March 11, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., March 11, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Report Fourth Quarter and Full Year 2012 Results
March 07, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the Cowen and Co. 33rd Annual Health Care Conference
February 27, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Announces Initiation of Investigator-Initiated Study Evaluating TSO in Psoriasis
February 25, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Signs Research Collaboration and License Agreement With Freie Universitat Berlin for Secretory Products of Trichuris suis
February 22, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 22, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Participate in Panel Discussion at the Citi 2013 Global Healthcare Conference
February 19, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 19, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the Leerink Swann 2013 Global Healthcare Conference
February 07, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...